News Medical on MSN
The Jackson Laboratory receives an up to $30 million contract award to revolutionize drug safety testing with AI-powered “virtual hearts”
Developing new drugs is one of the riskiest and most expensive endeavors in science. Today, The Jackson Laboratory (JAX) announced a bold initiative to improve that trajectory, powered by an up to $30 ...
Predicting how a person’s heart will respond to a new medicine remains one of the most persistent blind spots in drug ...
The Yili Innovation Centre Oceania has since been involved in breakthrough research with major global health implications, ...
Step inside the Soft Robotics Lab at ETH Zurich, and you find yourself in a space that is part children's nursery, part ...
18don MSN
A new reference brain could make the clonal raider ant a go-to model species for neuroscience
Scientists have created the first reference brain for the clonal raider ant. They used the tool to make unexpected discoveries, including variation among the individual ant brains that may relate to ...
Beyond better testing, we need better protection. Physical shields seem like the obvious first defense. Hydrogen-rich materials such as polyethylene and water-absorbing hydrogels can slow charged ...
Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
Scientists reveal a hidden brain code that tracks distance and time in the dark, offering new insight into navigation and ...
Morning Overview on MSN
Brain scans reveal an internal "dial" that keeps you from getting lost
Human navigation turns out to be less like following a static map and more like tuning a control knob inside the brain. New ...
Morning Overview on MSN
Scientists built a working brain, and the stakes just exploded
Researchers have crossed a threshold that once belonged squarely to science fiction: they have built working models of brains, both in silicon and in living tissue, that can learn, adapt, and even ...
KOMZIFTI (ziftomenib), the first and only once-daily oral menin inhibitor for adult patients with R/R AML with a susceptible NPM1 mutation who have no satisfactory alternative treatment options, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results